Profile
Marcelle Machluf is the founder of NanoGhost Ltd., founded in 2019, serving as Director.
The current job is Associate Professor at Technion-Israel Institute of Technology.
Former job includes External Director at Erech Finance Cahalacha Ltd. from 2010 to 2019.
Education includes undergraduate degree from The Hebrew University of Jerusalem and graduate and doctorate degrees from Ben-Gurion University of the Negev.
Marcelle Machluf active positions
| Companies | Position | Start |
|---|---|---|
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
NanoGhost Ltd.
NanoGhost Ltd. Packaged SoftwareTechnology Services Develops drug delivery platform from membrane of mesenchyme stem cells | Founder | 2019-08-13 |
Former positions of Marcelle Machluf
| Companies | Position | End |
|---|---|---|
| ERECH FINANCE CAHALACHA LTD | Director/Board Member | 2019-10-26 |
Training of Marcelle Machluf
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erech Finance Cahalacha Ltd.
Erech Finance Cahalacha Ltd. Medical SpecialtiesHealth Technology Engages in the research and development of insulin treatment methods | Health Technology |
NanoGhost Ltd.
NanoGhost Ltd. Packaged SoftwareTechnology Services Develops drug delivery platform from membrane of mesenchyme stem cells | Technology Services |
- Stock Market
- Insiders
- Marcelle Machluf
















